
Nectar Lifesciences announces strategic sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores
Nectar Lifesciences Limited (NSE: NECLIFE, BSE: 532649), a leading pharmaceutical company, today announced the signing of a definitive Business Transfer Agreement (BTA) for the sale of its core business division-comprising the manufacture, distribution, …